watch the close. Some of this may have been bought in anticipation, but I will bet you $1 that end of day close volume will be $2MM+ and it's under 1MM at 2:34 and average daily is about 1.1MM. No prediction on price.
ARNA the wannabie has tons of potential to be just like them, but shorts have their foot on the throat of ARNA. Some new clinical progress could get this stock flying and finally reward the long suffering ARNA shareholders similar to AVNR.
Some stupid kid with a computer that think's he's something, or just another paid basher working out of the hedge fund broom closet with big $dreams. Get a life loser!
I need this stock to slow down, below $25 on Friday please, then squeeze. I hate buying calls back, but love when they finish close to the $$$.
no, I think shorts are trying to get our hopes up before the cc, so they can crush hope and JL during the call...
they do have a lot of cash, but AP/payables is also very high. I was looking at the BS recently and wondering about payables, can anyone explain why so high? Also, I think book may be overstated, but I would be very happy with $4-5 since I have a nice position in the mid $2's.
I also bought BBEP a POS stock in terms of performance compared to GTE. Must be debt vs no debt and brent vs WTI that's making the difference. BBEP is very hedged at high prices...
Most firms won't pay more than a 100% premium no matter what a firm is "worth". So, unless ARNA rallies on some significant new clinical developments, at the current stock price, it's unlikely anyone will offer more then $9. I could also see the potential for a company to buy Belviq and spin out, or do something creative with the pipeline. It might take a failure in the pipeline to force Jack to sell, he seems content to continue soaking and diluting the shareholders.
Nice, Jeff was negative before the first FDA turn down, then went positive before the second try and approval. The analyst Wei turned bullish based on Bel-phen potential, which has not yet materialized, but overall they seem to be the most accurate firm covering the company.
Checking the chart, it appears EXAS has tested and retested the lows successfully and is now poised to test first resistance in the low $24's. If successful, a rapid move to around $26 is very possible (just not until after next Friday I hope).
very reasonable. As for Anthony, I doubt Eisai can just sell off their rights to another firm without ARNA's approval. I do think it's very possible a split is coming, or maybe they just don't want to make the investment in commercial until the market can be broadened and as stated, that will take more time and investment.
what are shorts going to do, cover, or stay put? I thought this would be a big down open followed by covering. I was expecting max volatility??? Nice of them to throw the LAR bone.
Eisai, let our people go to pursue max shareholder value or we will send plagues!